Status:
COMPLETED
Evaluating the Effect of Mucinex® 1200 mg on Mucociliary and Cough Clearance From the Human Lung
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
Reckitt Benckiser Inc.
Conditions:
Mucociliary Clearance
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
The purpose of this research study is to test the ability of Mucinex, an oral, over-the-counter, FDA approved expectorant) to stimulate the clearance of inhaled particles from the subject's lungs (cal...
Eligibility Criteria
Inclusion
- Healthy
- Non smoker
- BMI 19-29
- Normal lung function
Exclusion
- Pregnant
- Smokers
- Any illness
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00902707
Start Date
May 1 2009
End Date
May 1 2012
Last Update
June 11 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UNC Center for Environmental Medicine, Asthma and Lung Biology
Chapel Hill, North Carolina, United States, 27599